Anhui Anke BioTech Group Cash Flow Reinvestment Rate
Anhui Anke BioTech Group cash flow reinvestment rate. Anhui Anke BioTech Group (300009) has a Cash Flow Reinvestment Rate of 0.09x as of September 2025, reinvesting CN¥21.63 Million (capex CN¥21.63 Million ) from operating cash flow of CN¥240.51 Million. Explore cash flow to debt ratio of Anhui Anke BioTech Group to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Anhui Anke BioTech Group (2006–2025)
Cash flow reinvestment rate of Anhui Anke BioTech Group from 2006 to 2025. Historical reinvestment intensity for Anhui Anke BioTech Group across 20 annual periods. Explore 300009 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Anhui Anke BioTech Group Cash Flow Reinvestment Rate by Year (2006–2025)
Anhui Anke BioTech Group cash flow reinvestment rate by year from 2006 to 2025. Year-by-year capital reinvestment analysis for Anhui Anke BioTech Group. For the full cash flow conversion analysis, see Anhui Anke BioTech Group cash conversion from operations.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.55x | CN¥473.05 Million | CN¥863.22 Million | CN¥126.89 Million | ▲ +114.7% |
| 2024 | 0.26x | CN¥174.93 Million | CN¥685.37 Million | CN¥117.22 Million | ▼ -60.6% |
| 2023 | 0.65x | CN¥617.17 Million | CN¥952.97 Million | CN¥195.34 Million | ▼ -21.3% |
| 2022 | 0.82x | CN¥575.41 Million | CN¥698.98 Million | CN¥474.34 Million | ▲ +108.1% |
| 2021 | 0.40x | CN¥234.30 Million | CN¥592.17 Million | CN¥131.23 Million | ▼ -52.8% |
| 2020 | 0.84x | CN¥389.76 Million | CN¥464.80 Million | CN¥138.52 Million | ▼ -63.8% |
| 2019 | 2.32x | CN¥684.87 Million | CN¥295.63 Million | CN¥186.48 Million | ▲ +190.7% |
| 2018 | 0.80x | CN¥229.13 Million | CN¥287.49 Million | CN¥213.72 Million | ▼ -4.5% |
| 2017 | 0.83x | CN¥234.17 Million | CN¥280.63 Million | CN¥131.78 Million | ▲ +207.4% |
| 2016 | 0.27x | CN¥70.04 Million | CN¥258.01 Million | CN¥69.18 Million | ▼ -75.4% |
| 2015 | 1.10x | CN¥131.05 Million | CN¥118.73 Million | CN¥36.95 Million | ▲ +36.3% |
| 2014 | 0.81x | CN¥88.04 Million | CN¥108.68 Million | CN¥88.04 Million | ▲ +36.3% |
| 2013 | 0.59x | CN¥31.64 Million | CN¥53.21 Million | CN¥31.64 Million | ▼ -46.2% |
| 2012 | 1.10x | CN¥59.42 Million | CN¥53.80 Million | CN¥59.42 Million | ▼ -90.4% |
| 2011 | 11.49x | CN¥82.54 Million | CN¥7.18 Million | CN¥82.54 Million | ▲ +4776.0% |
| 2010 | 0.24x | CN¥11.18 Million | CN¥47.43 Million | CN¥11.18 Million | ▼ -27.3% |
| 2009 | 0.32x | CN¥12.54 Million | CN¥38.67 Million | CN¥12.54 Million | ▲ +29.4% |
| 2008 | 0.25x | CN¥6.52 Million | CN¥26.04 Million | CN¥6.52 Million | ▼ -5.7% |
| 2007 | 0.27x | CN¥9.32 Million | CN¥35.10 Million | CN¥9.32 Million | ▲ +206.2% |
| 2006 | 0.09x | CN¥2.57 Million | CN¥29.66 Million | CN¥2.57 Million | — |